Literature DB >> 20012521

Host restriction of HIV-1 by APOBEC3 and viral evasion through Vif.

Anna Maria Niewiadomska1, Xiao-Fang Yu.   

Abstract

The arms race between virus and host is a constant battle. APOBEC3 proteins are known to be potent innate cellular defenses against both endogenous retroelements and diverse retroviruses. However, retroviruses have developed their own methods to launch counter-strikes. Most primate lentiviruses encode a protein called the viral infectivity factor (Vif). Vif induces targeted destruction of APOBEC3 proteins by hijacking the cellular ubiquitin-proteasome pathway. Here we review the research that led up to the identification of A3G, the mechanisms by which APOBEC3 proteins can inhibit retroelements, and the counter-mechanisms that HIV-1 Vif has developed to evade its antiviral activities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20012521     DOI: 10.1007/978-3-642-02175-6_1

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  17 in total

1.  Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions.

Authors:  Wenyan Zhang; Juan Du; Kevin Yu; Tao Wang; Xiong Yong; Xiao-Fang Yu
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity.

Authors:  Xiaojun Wang; Aierken Abudu; Sungmo Son; Ying Dang; Patrick J Venta; Yong-Hui Zheng
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

3.  Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.

Authors:  Ying Dang; Roderick W Davis; Ian A York; Yong-Hui Zheng
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

4.  APOBEC3G complexes decrease human immunodeficiency virus type 1 production.

Authors:  Kenneth L Martin; Megan Johnson; Richard T D'Aquila
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

5.  Differential requirements for HIV-1 Vif-mediated APOBEC3G degradation and RUNX1-mediated transcription by core binding factor beta.

Authors:  Juan Du; Ke Zhao; Yajuan Rui; Peng Li; Xiaohong Zhou; Wenyan Zhang; Xiao-Fang Yu
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

6.  Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.

Authors:  Ying Dang; Xiaojun Wang; Ian A York; Yong-Hui Zheng
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

7.  Inhibition of cellular proteasome activities mediates HBX-independent hepatitis B virus replication in vivo.

Authors:  Zhensheng Zhang; Eun Sun; Jing-hsiung James Ou; T Jake Liang
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

8.  Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase.

Authors:  Xue Han; Weizi Liang; Deping Hua; Xiaohong Zhou; Juan Du; Sean L Evans; Qimeng Gao; Hong Wang; Rachel Viqueira; Wei Wei; Wenyan Zhang; Xiao-Fang Yu
Journal:  J Virol       Date:  2014-01-03       Impact factor: 5.103

9.  CBFβ enhances de novo protein biosynthesis of its binding partners HIV-1 Vif and RUNX1 and potentiates the Vif-induced degradation of APOBEC3G.

Authors:  Eri Miyagi; Sandra Kao; Venkat Yedavalli; Klaus Strebel
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

10.  The local dinucleotide preference of APOBEC3G can be altered from 5'-CC to 5'-TC by a single amino acid substitution.

Authors:  Anurag Rathore; Michael A Carpenter; Özlem Demir; Terumasa Ikeda; Ming Li; Nadine M Shaban; Emily K Law; Dmitry Anokhin; William L Brown; Rommie E Amaro; Reuben S Harris
Journal:  J Mol Biol       Date:  2013-08-11       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.